Advancing the early detection of canine cognitive dysfunction syndrome with machine learning-enhanced blood-based biomarkers

HIGHLIGHTS

• What: This study explored novel biomarkers using methodologies similar to those used to identify effective biomarkers of classical AD and PD in experimental animals . By observing how these biomarkers respond to treatment in animals diagnosed with CCDS, the authors aim to assess the effectiveness of the biomarkers .
• Who: Chae Young Kim from the University of Veterinary Medicine Hannover, Germany have published the research: Advancing the early detection of canine cognitive dysfunction syndrome with machine learning-enhanced blood-based biomarkers, in the Journal: (JOURNAL)
• How: The results indicated that among the 111 inflammatory cytokine . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.